DCF Advisers, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,586,000
+3.5%
3,050,0000.0%0.86%
+6.7%
Q2 2023$1,532,625
+3.8%
3,050,000
-15.3%
0.81%
-10.4%
Q1 2023$1,476,000
+642.1%
3,600,0000.0%0.90%
+574.6%
Q4 2022$198,900
-77.5%
3,600,000
+132.3%
0.13%
-76.5%
Q3 2022$884,000
+116.7%
1,550,000
+106.7%
0.57%
+135.0%
Q2 2022$408,000
+91.5%
750,000
+87.5%
0.24%
+161.3%
Q1 2022$213,000
+0.9%
400,0000.0%0.09%
+8.1%
Q4 2021$211,000400,0000.09%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders